Abstract
Remarkable advances in blood transfusion and iron-chelation therapy have improved and prolonged the survival of patients with thalassemic syndromes. Because of this increase in mean survival, new therapeutic strategies have been designed in order to limit the most important complications involving heart, liver and endocrine tissues. Endocrine disorders are rarely reported as cause of death in thalassemics but they can worsen the quality of life of these patients. Most authors have reported high incidence of endocrine abnormalities in thalassemics and the iron overload is frequently indicated as the most important pathogenetic factor [1]. De Sanctis et al. [2], in a multicenter study, reported that endocrine abnormalities involve more than 50% of thalassemic patients. Particularly the incidence of thyroid disorders has shown a large variability, according to the findings reported in the various studies [3–5]. The aim of this study was to evaluate the thyroid function in 58 thalassemic patients in order to evaluate possible correlations with age, serum ferritin values, and liver impairment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Castriota Scanndemberg A, Fenozzi F, Butturini A, Izzi G, Zavota L, Casa F, Giovanneli G (1990) Lo studio del sovraccarico di ferro in soggetti talassemici mediante risonanza magnetica nuclear. Riv Ital Pediatr 16: 294 - 299
De Sanctis V et al. (1990) Prevalence of endocrine complications in patients with beta-thalassemia major. J Endocrinol Invest 13 [Suppl 3]: 114
Chatziliami A, Mengreli C, Katsantoni A et al. (1991) Thyroid function in thalassemia. Congres International sur les Maladies Genetique de I’Hemoglobine, Nov, Nice-Acropolis
Martino E, Lai E, Balzano S et al. ( 1991 ) Thyroid function in thalassemia. Congres International sur les Maladies Genetique de I’Hemoglobine, Nov, Nice-Acropolis
Magro S, Puzzonia P, Consarino C et al. (1990) Hypothyroidism in patients with thalassemic syndromes. Acta Haematol (Basel) 84: 72–76
Martino E, Lai E, Balzano S, Murtas ML, Figus A (1990) Thyroid function in thalassemia. J Endocrinol Invest 13 [Suppl 3]: 99
Halliwell B (1989) Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic Biol Med 7: 645 - 651
Bompiani GD, Galluzzo A (1990) Radicali liberi in fisiologia e patologia. Minerva Medica, Torino
Bacon B, Britton R (1990) The pathology of hepatic iron overload: a free radical-mediated process? Hepatology 2: 127–137
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pitrolo, L., Lo Pinto, C., D’Angelo, P., Malizia, R., Lo Iacono, F. (1995). Evaluation of Thyroid Function in Thalassemic Patients Undergoing Long-term Blood Transfusion and Iron-Chelation Therapy. In: Andò, S., Brancati, C. (eds) Endocrine Disorders in Thalassemia. Springer, Milano. https://doi.org/10.1007/978-88-470-2183-9_20
Download citation
DOI: https://doi.org/10.1007/978-88-470-2183-9_20
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2185-3
Online ISBN: 978-88-470-2183-9
eBook Packages: Springer Book Archive